MDPV and α-PVP use in humans: The twisted sisters.
Laurent Karila, Geneviève Lafaye, Amandine Scocard, Olivier Cottencin, Amine Benyamina
Neuropharmacology May 15, 2018 DOI: 10.1016/j.neuropharm.2017.10.007 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Keywords | Adverse effects Alpha-pvp Fatalities Mdpv New psychoactive substances Synthetic cathinones |
| Key findings | The authors argue that MDPV and α-PVP, potent pyrovalerone synthetic cathinones, pose a considerable public health challenge, with clinical effects varying by individual, dose, and route of administration. They state that both compounds have been involved in an increasing number of acute intoxications and fatalities in recent years, and conclude that health actors and the general public need clear information about the risks of these substances. |
Abstract
The new psychoactive substances phenomenon continues to represent a considerable public health challenge. Synthetic cathinones are β-keto amphetamine analogues, also known as legal highs, research chemicals, bath salts. These drugs have surfaced as a popular alternative to other illicit drugs of abuse, such as cocaine, MDMA, and methamphetamine, due to their potent psychostimulant and empathogenic effects. Pyrovalerone cathinones (a-pyrrolidinophenones) form a distinct group of designer cathinones, such as MDPV. After being listed as an illegal product, "second generation" compounds such as α-PVP, sharing a very similar chemical structure with MDPV, were developed. Clinical effects of these compounds are individual, dose- and route of administration-dependent. Both of them have been involved in an increased number of, not only acute intoxications but also fatalities over the past few years, raising concerns in the medical field. In this paper, we will review the available data regarding the use and effects of MDPV and α-PVP in humans in order to highlight their impact on public health. Health actors and general population need to be clearly informed of potential risks and consequences of these 2 novel psychoactive substances spread and use. The literature search conducted led to the identification of potentially 83 relevant articles. All articles were screened from their abstracts to determine their relevance in the framework of the current review. This article is part of the Special Issue entitled 'Designer Drugs and Legal Highs.'
Citations in the library
Cited by 3
- Acute pharmacological effects of α-PVP in humans: a naturalistic observational study. Frontiers in Pharmacology 2025
- Effects of Serial Polydrug Use on the Rewarding and Aversive Effects of the Novel Synthetic Cathinone Eutylone Brain Sciences September 7, 2023
- The MDPV Derivative α-PHP Regulates Cellular Differentiation and Triggers Apoptotic Cell Death and Ultrastructural Changes in Murine 3D Neurospheres Molecules July 13, 2026
Cites 5
- Designer drugs 2015: assessment and management Addiction Science & Clinical Practice March 11, 2015
- Psychosis associated with acute recreational drug toxicity: a European case series. BMC Psychiatry August 18, 2016
- Bath salts and synthetic cathinones: an emerging designer drug phenomenon. Life Sciences February 27, 2014
- Bath salts, mephedrone, and methylenedioxypyrovalerone as emerging illicit drugs that will need targeted therapeutic intervention. Advances in pharmacology (San Diego, Calif.) 2014
- GHB and synthetic cathinones: clinical effects and potential consequences. Drug Testing and Analysis September 2011